Russell Investments Group, Ltd. - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 127 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,091
-12.9%
20,8000.0%0.00%
Q2 2023$9,287
-45.5%
20,8000.0%0.00%
Q1 2023$17,056
-47.4%
20,8000.0%0.00%
Q4 2022$32,448
-7.3%
20,8000.0%0.00%
Q3 2022$35,0000.0%20,8000.0%0.00%
Q2 2022$35,000
-52.7%
20,8000.0%0.00%
Q1 2022$74,000
-28.2%
20,8000.0%0.00%
Q4 2021$103,000
-30.4%
20,8000.0%0.00%
Q3 2021$148,000
-47.5%
20,800
-31.7%
0.00%
Q2 2021$282,0000.0%30,4610.0%0.00%
Q1 2021$282,000
+44.6%
30,461
+37.9%
0.00%
Q4 2020$195,000
-46.9%
22,091
-30.4%
0.00%
-100.0%
Q3 2020$367,000
+41.2%
31,752
+228.7%
0.00%0.0%
Q2 2020$260,000
+233.3%
9,661
-48.7%
0.00%
Q4 2017$78,000
-34.5%
18,8350.0%0.00%
Q3 2017$119,000
-74.7%
18,835
-68.6%
0.00%
-100.0%
Q2 2017$471,000
-8.4%
60,027
-22.8%
0.00%0.0%
Q1 2017$514,000
-8.1%
77,709
-3.7%
0.00%0.0%
Q4 2016$559,00080,6910.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders